Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
The Latest Google Headlines on:
The Latest Bing News on:
- Cancer Immunotherapy Market 2019 Industry Share, Size, Statistics, Growth, Opportunity, Trends, Regional Analysis with Global Forecast To 2023on December 6, 2019 at 2:15 am
Amgen Inc., Bristol-Myers Squibb, ELI Lilly and Company, Celgene Corporation, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc. Get Exclusive Free Sample Copy ...
- Cancer Immunotherapy Market Will Grow At A CAGR of 7.5% During Forecast Period 2018-2027on December 6, 2019 at 12:39 am
Dec 06, 2019 (AmericaNewsHour) -- Market Trends in Global Cancer Immunotherapy Market Roche Pharma and India's third largest drug maker Cipla tied up to promote and distribute tocilizumab (Actemra) ...
- Brain immunology and immunotherapy in brain tumourson December 5, 2019 at 9:30 am
Yet, seminal discoveries in the past 5 years have clarified the anatomy, genetics and function of the immune system within the central nervous system (CNS) and altered the paradigm for successful ...
- Cancer Treatment Centers of America Continues Pioneering Efforts in Immuno-Oncology; Doses First Patient in Novel Immunotherapy Clinical Trialon December 5, 2019 at 6:00 am
PHOENIX, Dec. 5, 2019 /PRNewswire/ -- Clinical investigators at Cancer Treatment Centers of America® (CTCA) in Phoenix have dosed the first patient in the first-in-human study of NKTR-255, a ...
- Resurrecting Anti-Tumor Activity in T Cells to Improve Responses to Cancer Immunotherapyon December 5, 2019 at 5:30 am
It, therefore, should speed the development of new cancer and infectious-disease immunotherapies, including those that can be combined with existing immunotherapy drugs to enhance their effects, ...
- Immunotherapy leads the way for melanoma treatmenton December 4, 2019 at 2:06 pm
But she soon learned of another approach that held promise for her type of cancer: immunotherapy, a cancer treatment that triggers a person’s own immune system to kill the cancer cells within their ...
- Roche wins FDA approval for immunotherapy cocktail against lung canceron December 3, 2019 at 10:42 pm
Roche’s Tecentriq immunotherapy mixed with chemotherapy won U.S. approval as an initial treatment for a form of lung cancer as the Swiss drugmaker seeks to establish its alternative to drugs from ...
- Transition to exhaustion: Clues for cancer immunotherapyon December 3, 2019 at 1:22 pm
Research on immune cells "exhausted" by chronic viral infection provides clues on how to refine cancer immunotherapy. The results are scheduled for publication in Immunity. Scientists at Emory Vaccine ...
- Immunotherapy is safe following chemoradiotherapy for women with node-positive cervical canceron December 3, 2019 at 7:03 am
Results from the NRG Oncology phase I clinical trial NRG-GOG 9929 show that using the immunotherapy drug ipilimumab after chemoradiotherapy (CRT) is tolerated in the curative treatment of women with ...
- Immunotherapy Drugs Markets: Worldwide Growth, Trends and Forecasts to 2024 - ResearchAndMarkets.comon December 2, 2019 at 10:25 am
DUBLIN--(BUSINESS WIRE)--The "Immunotherapy Drugs Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The Immunotherapy Drugs Market ...
The Latest Google Headlines on:
Artificial intelligence diagnostics
The Latest Bing News on:
Artificial intelligence diagnostics
- Artificial Intelligence (AI) in Healthcare Market Rewriting it's Growth Cycle | Microsoft, IBM, Aindraon December 6, 2019 at 10:27 am
Artificial intelligence is used in six healthcare segments: hospitals, pharmaceuticals, diagnostics, medical equipment and supplies, medical insurance, and telemedicine. Artivatic Data Labs Private ...
- Ethical artificial intelligenceon December 5, 2019 at 2:23 am
Artificial Intelligence (AI) is acquiring increasing importance in many applications that ... Therefore, despite reaching new extraordinary goals using machines (like flying, landing on the moon, ...
- Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnosticson December 5, 2019 at 12:00 am
Dec 05, 2019 (GLOBE NEWSWIRE via COMTEX) -- December 5, 2019 AI-based cancer assessment tools are poised to help pathologists improve speed and accuracy of cancer diagnostics, ultimately leading to ..
- How enterprises can prepare for ‘continuous intelligence’on December 4, 2019 at 5:01 pm
Enrich descriptive and diagnostic analytics with storytelling ... focusing on the creation of societal and business value from real-time data and artificial intelligence as the key enabler of digital ...
- iCAD’s ProFound AI Joins Nuance AI Marketplace for Diagnostic Imagingon December 4, 2019 at 4:31 pm
The Nuance AI Marketplace functions like an app store dedicated to radiology; it is the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the ...
- Analysis on the World Market for Artificial Intelligence (AI) in Healthcare, 2019-2024: Current & Future Opportunitieson December 3, 2019 at 8:49 am
Dublin, Dec. 03, 2019 (GLOBE NEWSWIRE) -- The "The Market for Artificial Intelligence (AI) in Healthcare" report has been added to ... drug discovery and emerging applications in diagnostics and other ...
- Braid.Health to Showcase Universal Access to Accelerated Diagnostic Image Interpretation at RSNA 2019on December 2, 2019 at 11:45 am
SAN FRANCISCO, Dec. 2, 2019 /PRNewswire-PRWeb/ -- Braid.Health, developer of advanced artificial intelligence (AI) technology supporting radiologists and ... Braid is designed to close the gap in care ...
- Artificial Intelligence in Radiology Market 2019 Size, Share, Upcoming Trends, Segmentation and Forecast to 2025 | CAGR of 35.9%on December 2, 2019 at 1:42 am
Also, the Center will link academic innovations to startups to sponsor collective AI imaging R&D. The artificial intelligence in radiology market is driven by the factors such as use of machine ...
- Can Artificial Intelligence Break Your Porn Habit? Lamar Odom Thinks Soon December 1, 2019 at 3:30 am
But if you were a social conservative, you might also say that the market-driven internet is a snake pit waiting to snare the righteous—so obviously, artificial intelligence (AI) is the solution ...
- Care Mentor AI's artificial intelligence system for radiologists at RSNA 2019on November 27, 2019 at 8:10 am
"We can't wait to present our solutions at RSNA 2019." About Care Mentor AI solutions At our booth, visitors will be able to learn about the capabilities of our out-of-the-box AI-based diagnostic ...